J Rheum Dis.  2017 Apr;24(2):123-124. 10.4078/jrd.2017.24.2.123.

Add-on Clarithromycin and Tacrolimus Treatment for Rheumatoid Arthritis

• Ohe M

• KMID: 2378092
• DOI: http://doi.org/10.4078/jrd.2017.24.2.123

Abstract

No abstract available.

MeSH Terms

Arthritis, Rheumatoid*
Clarithromycin*
Tacrolimus*
Clarithromycin
Tacrolimus

Reference

1. Saviola G, Abdi Ali L, Rossini P, Campostrini L, Coppini A, Gori M, et al. Clarithromycin in rheumatoid arthritis patients not responsive to disease-modifying antirheumatic drugs: an open, uncontrolled pilot study. Clin Exp Rheumatol. 2002; 20:373–378.

2. Lee WS, Lee SI, Lee MS, Kim SI, Lee SS, Yoo WH. Efficacy and safety of low-dose tacrolimus for active rheumatoid arthritis with an inadequate response to methotrexate. Korean J Intern Med. 2016; 31:779–787.

3. Kunicki PK, Sobieszczańska-Małek M. Pharmacokinetic interaction between tacrolimus and clarithromycin in a heart transplant patient. Ther Drug Monit. 2005; 27:107–108.

4. Ohe M, Kataoka H, Mukai M. A case of lupus nephritis treated with clarithromycin, tacrolimus, and glucocorticoids. Kaohsiung J Med Sci. 2016; 32:484–485.

5. Inoue E, Yamanaka H, Hara M, Tomatsu T, Kamatani N. Comparison of Disease Activity Score (DAS)28-erythrocyte sedimentation rate and DAS28-C-reactive protein threshold values. Ann Rheum Dis. 2007; 66:407–409.